TTA Archives 2005-2012

MobiHealthNews discusses two recent Canadian studies reaching the conclusion that Type 2 diabetics not taking insulin receive only modest benefit from daily monitoring, and could reduce testing to once or twice a week.  The major conclusions are focused on cost savings, with daily testing considered to be ‘ineffective use of health resources.’  In other words, it’s money, not the benefit of self-monitoring which this editor believes would be valuable for non-insulin controlled diabetics.  The additional irony is the increasing prevalence of diabetes in Western countries has become a major mover of mHealth.  Article.  Science Daily report.